Literature DB >> 12777854

Living liver donation: preoperative assessment, anatomic considerations, and long-term outcome.

Hisanao Chisuwa1, Yasuhiko Hashikura, Atsuyoshi Mita, Shin-Ichi Miyagawa, Masaru Terada, Toshihiko Ikegami, Yuichi Nakazawa, Koichi Urata, Shiro Ogino, Seiji Kawasaki.   

Abstract

BACKGROUND: A major prerequisite for living donor liver transplantation (LDLT) as an acceptable treatment modality is thoughtful consideration of the donor. However, there has been no comprehensive audit of living liver donation focusing on issues such as donor selection, anatomic surveys, and long-term outcome.
METHODS: Between June 1990 and January 2002 at our institution, 160 LDLTs were performed and 177 patients were referred for LDLT. For these patients, a total of 203 potential donors were screened. The process of donor selection, safety of donor hepatectomy, and postoperative morbidity were investigated. Additionally, an anonymous questionnaire was administered to 100 donors who had undergone LDLT more than 3 years previously.
RESULTS: Thirty-eight (19%) of the 203 donor candidates were excluded. Precise estimation of the hepatic anatomy was indispensable for donor safety. None of the donors showed prolonged postoperative liver dysfunction nor developed complications requiring reoperation or readmission. There was no donor mortality. The responses to the questionnaire indicated that 95% of the living donors had not felt coerced to donate and that 5% were neutral about coercion pressure. There were no severe postoperative aftereffects, but minor problems were reported by 51% of the respondents.
CONCLUSIONS: Our appraisal of the perioperative and long-term postoperative course of LDLT donors revealed that although most donors are satisfied after undergoing LDLT, there is a need for strict attention to the process of donor selection and long-term postoperative follow-up. The outcome of the present series seems to confirm the safety of donor hepatectomy.

Entities:  

Mesh:

Year:  2003        PMID: 12777854     DOI: 10.1097/01.TP.0000063939.81744.3E

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Split-liver transplant for two adults in a spanish hospital.

Authors:  A Ríos; P Ramírez; R Robles; F Sánchez Bueno; P Parrilla
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

2.  Living donor liver transplantation: issues regarding left liver grafts.

Authors:  Y Hashikura; S Kawasaki
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

3.  Live liver donors' information needs: A qualitative study of practical implications for informed consent.

Authors:  Elisa J Gordon; Jack Mullee; Anton Skaro; Talia Baker
Journal:  Surgery       Date:  2016-06-04       Impact factor: 3.982

4.  Adult living donor liver transplantation: living donation of the right liver lobe.

Authors:  J Mittler; A Pascher; S Jonas; J Pratschke; U P Neumann; J M Langrehr; P Neuhaus
Journal:  Langenbecks Arch Surg       Date:  2007-04-14       Impact factor: 3.445

5.  De Novo Endotoxin-Induced Production of Antibodies against the Bile Salt Export Pump Associated with Bacterial Infection following Major Hepatectomy.

Authors:  Kun-Ming Chan; Chih-Hsien Cheng; Tsung-Han Wu; Chen-Fang Lee; Ting-Jung Wu; Hong-Shiue Chou; Wei-Chen Lee
Journal:  Biomed Res Int       Date:  2018-04-23       Impact factor: 3.411

6.  Clinical Features and Long-Term Outcomes of Living Donors of Liver Transplantation Who Developed Psychiatric Disorders.

Authors:  Masato Shizuku; Hideya Kamei; Hiroyuki Kimura; Nobuhiko Kurata; Kanta Jobara; Atsushi Yoshizawa; Kanako Ishizuka; Aoi Okada; Shinichi Kishi; Norio Ozaki; Yasuhiro Ogura
Journal:  Ann Transplant       Date:  2020-01-31       Impact factor: 1.530

7.  Risk of biliary tract disease in living liver donors: A population-based cohort study.

Authors:  Shih-Yi Lin; Cheng-Li Lin; Wu-Huei Hsu; I-Kuan Wang; Cheng-Chieh Lin; Long-Bing Jeng; Chia-Hung Kao
Journal:  PLoS One       Date:  2020-03-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.